HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Summit Trail Advisors LLC

Summit Trail Advisors LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.6% during the third quarter, Holdings Channel.com reports. The firm owned 3,612 shares of the company’s stock after buying an additional 433 shares during the period. Summit Trail Advisors LLC’s holdings in HCA Healthcare were worth $1,468,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Alpha DNA Investment Management LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth approximately $869,000. Larson Financial Group LLC increased its stake in HCA Healthcare by 201.3% in the third quarter. Larson Financial Group LLC now owns 672 shares of the company’s stock valued at $273,000 after purchasing an additional 449 shares during the last quarter. Swedbank AB boosted its stake in HCA Healthcare by 1.2% in the 3rd quarter. Swedbank AB now owns 286,219 shares of the company’s stock worth $116,328,000 after buying an additional 3,436 shares during the last quarter. Canopy Partners LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter valued at about $208,000. Finally, Kingsview Wealth Management LLC grew its holdings in HCA Healthcare by 396.1% in the third quarter. Kingsview Wealth Management LLC now owns 7,387 shares of the company’s stock valued at $3,002,000 after purchasing an additional 5,898 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 2.2 %

HCA stock opened at $324.93 on Monday. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market capitalization of $82.30 billion, a P/E ratio of 14.59, a PEG ratio of 1.25 and a beta of 1.68. The firm has a 50 day simple moving average of $379.40 and a 200-day simple moving average of $358.70.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HCA. UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, KeyCorp decreased their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Six equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Insiders Place Their Bets

In related news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 in the last quarter. Insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.